VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 56 filers reported holding VBI VACCINES INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $174 | -29.8% | 574,953 | -9.3% | 0.00% | – |
| Q4 2022 | $248 | -100.0% | 633,823 | -11.9% | 0.00% | – |
| Q3 2022 | $508,000 | -14.0% | 719,134 | -1.7% | 0.00% | – |
| Q2 2022 | $591,000 | -50.8% | 731,209 | -5.5% | 0.00% | – |
| Q1 2022 | $1,200,000 | -28.8% | 773,939 | +0.5% | 0.00% | – |
| Q4 2021 | $1,686,000 | -38.2% | 769,769 | -6.6% | 0.00% | -100.0% |
| Q3 2021 | $2,729,000 | -0.5% | 824,491 | +0.7% | 0.00% | 0.0% |
| Q2 2021 | $2,744,000 | +1.0% | 819,063 | -6.2% | 0.00% | 0.0% |
| Q1 2021 | $2,716,000 | +27.6% | 873,239 | +12.8% | 0.00% | 0.0% |
| Q4 2020 | $2,129,000 | -7.8% | 774,275 | -4.1% | 0.00% | 0.0% |
| Q3 2020 | $2,309,000 | -8.4% | 807,366 | -0.7% | 0.00% | 0.0% |
| Q2 2020 | $2,521,000 | +315.3% | 813,266 | +27.2% | 0.00% | – |
| Q1 2020 | $607,000 | +5.6% | 639,155 | +53.6% | 0.00% | – |
| Q4 2019 | $575,000 | +452.9% | 416,037 | +88.8% | 0.00% | – |
| Q3 2019 | $104,000 | -59.5% | 220,378 | 0.0% | 0.00% | – |
| Q2 2019 | $257,000 | – | 220,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 52,335,002 | $86,876,000 | 1.74% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $3,117,000 | 0.25% |
| Newbridge Financial Services Group, Inc. | 172,969 | $287,000 | 0.14% |
| Virtus ETF Advisers LLC | 69,220 | $115,000 | 0.05% |
| ArchPoint Investors | 65,000 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 115,365 | $192,000 | 0.03% |
| GRIMES & COMPANY, INC. | 281,077 | $467,000 | 0.02% |
| Cambridge Investment Research Advisors, Inc. | 2,189,700 | $3,635,000 | 0.02% |
| WEALTHSOURCE PARTNERS, LLC | 143,500 | $238,000 | 0.02% |
| CARDIFF PARK ADVISORS, LLC | 64,100 | $106,000 | 0.02% |